MACROMOLECULAR PRODRUGS

[21] CHANG TM, 1977, J BIOL CHEM, V252, P1515

[22] DIFFERENTIAL TOXICITY OF CARRIER-BOUND METHOTREXATE AGAINST TUMOR BONE-MARROW CELLS INVIVO [J]. BIOCHEMICAL PHARMACOLOGY, 1982, 31 (21) : 3513 - 3517

[23] CHU BCF, 1981, J PHARMACOL EXP THER, V219, P389

[24] CHU BCF, 1980, MOL PHARMACOL, V17, P382

[25] CHU BCF, 1977, MOL PHARMACOL, V13, P80

[26] DIFFERENTIAL TOXICITY OF CARRIER-BOUND METHOTREXATE TOWARD HUMAN-LYMPHOCYTES, MARROW AND TUMOR-CELLS [J]. BIOCHEMICAL PHARMACOLOGY, 1981, 30 (18) : 2545 - 2552

[27] CHU BCF, 1979, J NATL CANCER I, V62, P79

[28] EXPRESSION OF HORMONE RECEPTORS IN CANCER-CELLS - HYPOTHESIS [J]. EUROPEAN JOURNAL OF CANCER, 1978, 14 (03) : 211 - 215

[29] CUATRECASAS P, 1983, RECEPTORS RECOGNIT B, V15

[30] Dean RT, 1977, LYSOSOMES

[21] CHANG TM, 1977, J BIOL CHEM, V252, P1515

[22] DIFFERENTIAL TOXICITY OF CARRIER-BOUND METHOTREXATE AGAINST TUMOR BONE-MARROW CELLS INVIVO [J]. BIOCHEMICAL PHARMACOLOGY, 1982, 31 (21) : 3513 - 3517

[23] CHU BCF, 1981, J PHARMACOL EXP THER, V219, P389

[24] CHU BCF, 1980, MOL PHARMACOL, V17, P382

[25] CHU BCF, 1977, MOL PHARMACOL, V13, P80

[26] DIFFERENTIAL TOXICITY OF CARRIER-BOUND METHOTREXATE TOWARD HUMAN-LYMPHOCYTES, MARROW AND TUMOR-CELLS [J]. BIOCHEMICAL PHARMACOLOGY, 1981, 30 (18) : 2545 - 2552

[27] CHU BCF, 1979, J NATL CANCER I, V62, P79

[28] EXPRESSION OF HORMONE RECEPTORS IN CANCER-CELLS - HYPOTHESIS [J]. EUROPEAN JOURNAL OF CANCER, 1978, 14 (03) : 211 - 215

[29] CUATRECASAS P, 1983, RECEPTORS RECOGNIT B, V15

[30] Dean RT, 1977, LYSOSOMES